Rate My Professor Richard DiMarchi

Indiana University Bloomington

Chemistry Biology Medicine Health Science Biochemistry Chemical Biology Medicinal Chemistry Biotechnology Pharmacy and Pharmacology Endocrinology

5.0

1 review · out of 5

Rate Richard

Is this you? Claim this profile

Ratings & reviews

5.05/4/2026

Helps students see the bigger picture.

Taught by or worked with Richard?

Add your rating. It takes about 30 seconds.

About Richard

Richard DiMarchi is the Distinguished Professor of Chemistry and Linda & Jack Gill Chair in Biomolecular Sciences at Indiana University Bloomington, where he previously served as Department Chair from 2005 to 2007. He received his B.S. in Chemistry with honors from Florida Atlantic University in 1974, Ph.D. in Biochemistry from Indiana University in 1979 in the laboratory of Dr. Frank Gurd focusing on protein semisynthesis, and completed a postdoctoral fellowship at Rockefeller University from 1979 to 1981 in the laboratory of Dr. Bruce Merrifield on solid-phase chemical synthesis. From 1981 to 2003, he held progressive leadership roles at Eli Lilly & Company, culminating as Group Vice President of Biotechnology and Product Development, where he contributed to the discovery and development of landmark biologic medicines including rDNA-derived Humalog®, rGlucagon®, and Forteo®. DiMarchi has co-founded eight biotechnology companies since 2003, such as Ambrx, Marcadia Biotech, Calibrium, MB2, Assembly, and MBX, and serves or has served as a scientific advisor to Ferring, Merck, Roche, and several venture funds.